• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nutrien Reports Full-Year 2025 Results and Provides 2026 Guidance

    2/18/26 5:26:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials
    Get the next $NTR alert in real time by email
    • Full-year results demonstrate strong execution of our strategic plan and progress towards 2026 performance targets.
    • 2026 guidance reflects growth in upstream fertilizer sales volumes from our North American plants, higher Retail earnings, and a disciplined and consistent approach to capital allocation.

    All amounts are in US dollars, except as otherwise noted

    Nutrien Ltd. (TSX and NYSE:NTR) announced today its fourth quarter 2025 results, with net earnings of $0.58 billion ($1.18 diluted net earnings per share). Fourth quarter 2025 adjusted EBITDA1 was $1.28 billion and adjusted net earnings per share1 was $0.83.

    "2025 was a defining year for our Company, with exceptional performance across all our operating segments and a reduction in cost and capital expenditures that surpassed our targets. Alongside delivering structural free cash flow growth, we took decisive actions to optimize our portfolio, strengthen our balance sheet and increase cash returns to shareholders," commented Ken Seitz, Nutrien's President and CEO.

    "As we move into 2026, our priorities remain unchanged and we expect to build on our momentum supported by strong potash market fundamentals, an improved Nitrogen margin profile, and higher Retail earnings. I am excited about Nutrien's extraordinary potential as we continue to position the Company for long-term growth and resilience," added Mr. Seitz.

    Highlights2:

    • Generated net earnings of $2.30 billion and adjusted EBITDA of $6.05 billion for the full year of 2025. Adjusted EBITDA increased due to higher fertilizer net selling prices, record upstream fertilizer sales volumes and higher Retail earnings.
    • Generated strong free cash flow in 2025 and approximately $900 million in gross proceeds from asset divestiture proceeds since the fourth quarter of 2024, enabling a reduction in adjusted net debt and a 30 percent increase in total cash returns to shareholders.3
    • Retail adjusted EBITDA increased to $1.74 billion in 2025 due to lower operating expenses from our cost savings initiatives, stronger proprietary products gross margin and disciplined execution of our Brazil margin improvement plan. We continue to simplify our business and deliver earnings growth through proven organic initiatives.
    • Potash adjusted EBITDA increased to $2.25 billion in 2025 due to higher net selling prices and record sales volumes, supported by strong potash affordability and underlying consumption growth in key offshore markets. We mined 49 percent of our potash ore tonnes using automation, further strengthening our low-cost advantage.
    • Nitrogen adjusted EBITDA increased to $2.15 billion in 2025 due to higher net selling prices. Total ammonia production increased in 2025, supported by a four-percentage-point improvement in ammonia operating rate4 as we advanced reliability initiatives across our North American plants and completed low-cost debottlenecks at Redwater and Geismar.
    • We repurchased approximately 2 percent of our shares outstanding in 2025 for a total of $551 million. Nutrien's Board of Directors approved a 1 percent increase in the quarterly dividend to $0.55 per share and approved the purchase of up to 5 percent of outstanding common shares over a twelve-month period through a normal course issuer bid ("NCIB"). The NCIB is subject to acceptance by the Toronto Stock Exchange.

    1

    This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

    2

    Our discussion of highlights set out on this page is a comparison of the results for the twelve months ended December 31, 2025 to the results for the twelve months ended December 31, 2024, unless otherwise noted.

    3

    Cash used for dividends and share repurchases.

    4

    Excludes Trinidad and Joffre.

    Update on Strategic Actions:

    We continue to take actions to simplify our portfolio and focus on core assets to enhance earnings quality and free cash flow.

    • On December 10, 2025, we completed the sale of our 50 percent equity interest in Profertil S.A. ("Profertil") for approximately $0.6 billion. Since initiating portfolio actions in the fourth quarter of 2024, Nutrien has generated approximately $900 million in gross proceeds, enhancing capital efficiency and portfolio resilience while strengthening the balance sheet and increasing cash returns to shareholders.
    • We are progressing as planned with the review of strategic alternatives for our Phosphate business and intend to solidify the optimal path in 2026.
    • We continue to assess options for our Trinidad Nitrogen facility, and consistent with our approach of reviewing non-core assets, we ceased production at our New Madrid Nitrogen upgrade facility at year-end 2025. Our Trinidad and New Madrid plants combined accounted for approximately 1.6 million tonnes of Nitrogen sales volumes in 2025, however contributed marginal free cash flow. These portfolio actions improve the margin profile of our Nitrogen business, allow for greater focus on enhancing our core North American assets, and provide increased stability to consolidated free cash flow.





    Market Outlook and Guidance

    Agriculture and Retail Markets

    • Higher global grain and oilseed production in 2025 increased stocks-to-use ratios towards historical average levels and led to significant nutrient removal from the soil. Strong demand for food, feed and biofuel uses is expected to drive continued need for higher global crop production and related crop inputs.
    • We expect total US crop acres in 2026 to be consistent with 2025 levels and project corn plantings of 94 to 96 million acres and soybean plantings of 84 to 86 million acres. This acreage outlook, combined with a compressed fertilizer application season in the fall of 2025, is expected to support increased crop input demand in the first half of 2026.
    • In Brazil, soybean production is expected to set another record in 2026, with harvest currently underway, and we anticipate a 3 to 5 percent increase in safrinha corn plantings. Growth in planted area is expected to support crop input demand; however, weaker affordability is expected to result in just-in-time purchases and a continued shift to lower analysis nitrogen and phosphate products.
    • In Australia, improved weather compared to the first half of 2025 is expected to support crop input demand and strong livestock prices to support sales of Retail products and services.

    Crop Nutrient Markets

    • Global potash shipments increased to approximately 74.5 million tonnes in 2025, primarily driven by strong demand in Southeast Asia. We expect a fourth consecutive year of growth in 2026, with total global potash shipments ranging between 74 and 77 million tonnes. Demand is supported by the need to replenish soil nutrients following a record crop, favorable relative affordability and low inventory levels in key markets such as China and Brazil. We anticipate relatively tight fundamentals throughout 2026, as trend line demand growth is testing existing global operating and supply chain capabilities.
    • Global nitrogen demand is expected to grow in line with historical rates, driven by increasing use in agricultural growth markets such as Asia and Latin America. Global ammonia markets remain tight due to project delays and plant outages. Global urea markets have strengthened in the first quarter of 2026 due to strong seasonal demand from India, North America and Brazil and geopolitical uncertainties impacting supply.
    • Global phosphate markets eased in the fourth quarter of 2025 due to lower demand related to weaker affordability relative to potash and nitrogen. Phosphate markets have strengthened in the first quarter of 2026 due to Chinese export restrictions and elevated input costs.

    Financial and Operational Guidance

    • Retail adjusted EBITDA guidance of $1.75 to $1.95 billion represents continued structural growth in our downstream business consistent with historical rates. The mid-point of our guidance range assumes high-single digit growth in proprietary products gross margins, a mid-single digit increase in our North American crop nutrient sales volumes, improved weather conditions in Australia and cost reduction initiatives across all geographies.
    • Potash sales volume guidance of 14.1 to 14.8 million tonnes is consistent with our global shipment expectation.
    • Nitrogen sales volume guidance of 9.2 to 9.7 million tonnes assumes no production from our Trinidad and New Madrid facility, which accounted for approximately 1.4 million tonnes and 0.2 million tonnes, respectively, in 2025. Nitrogen sales volumes are supported by planned reliability improvements and debottlenecks.
    • Phosphate sales volume guidance of 2.4 to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.
    • Total capital expenditures of $2.0 to $2.1 billion is consistent with 2025 as we continue to optimize capital to sustain safe and reliable operations and to progress a set of targeted growth investments. The total includes approximately $400 million in investing capital focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions and product optimization projects in Nitrogen, and mine automation in Potash.

    All guidance numbers, including those noted above, are outlined in the table below. In addition, set forth below are anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

     

    2026 Guidance ranges1 as of

    February 18, 2026

     

    ($ billions, except as otherwise noted)

    Low

    High

    2025 Actual

    Retail adjusted EBITDA

    1.75

    1.95

    1.74

    Potash sales volumes (million tonnes) 2

    14.1

    14.8

    14.25

     

    Nitrogen sales volumes (million tonnes) 2

    9.2

    9.7

    10.89

    Phosphate sales volumes (million tonnes) 2

    2.4

    2.6

    2.36

    Depreciation and amortization

    2.4

    2.5

    2.4

    Finance costs

    0.65

    0.75

    0.7

    Effective tax rate on adjusted net earnings (%) 3

    24.0

    26.0

    24.9

    Capital expenditures 4

    2.0

    2.1

    2.0

    1 See the "Forward-Looking Statements" section.

    2 Manufactured product only.

    3 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the "Other Financial Measures" section.

    2026 Annual Sensitivities

    Effect on1

    ($ millions, except EPS amounts)

    Adjusted EBITDA

    Adjusted EPS4

    $25 per tonne change in potash net selling prices

    ± 280

    ± 0.45

    $25 per tonne change in ammonia net selling prices 2

    ± 35

    ± 0.05

    $25 per tonne change in urea and ESN® net selling prices

    ± 65

    ± 0.10

    $25 per tonne change in solutions, nitrates and sulfates net selling prices

    ± 135

    ± 0.20

    $1 per MMBtu change in NYMEX natural gas price 3

    ± 180

    ± 0.30

    1 See the "Forward-Looking Statements" section.

    2 Excludes Trinidad.

    3 Nitrogen related impact.

    4 Based on shares outstanding as at December 31, 2025.

     
     

    Consolidated Results

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    ($ millions, except as otherwise noted)

    2025

    2024

    % Change

     

    2025

    2024

    % Change

    Sales

    5,340

    5,079

    5

     

    26,885

    25,972

    4

    Gross margin

    1,888

    1,581

    19

     

    8,347

    7,530

    11

    Expenses

    967

    1,184

    (18)

     

    4,611

    5,674

    (19)

    Net earnings

    580

    118

    392

     

    2,297

    700

    228

    Adjusted EBITDA 1

    1,277

    1,055

    21

     

    6,046

    5,355

    13

    Diluted net earnings per share (dollars) 2

    1.18

    0.23

    413

     

    4.66

    1.36

    243

    Adjusted net earnings per share (dollars) 1, 2

    0.83

    0.31

    168

     

    4.56

    3.47

    31

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

    Net earnings and adjusted EBITDA increased in the fourth quarter primarily due to higher fertilizer net selling prices and Potash sales volumes, partially offset by lower Nitrogen sales volumes and Retail earnings. For the full year of 2025, net earnings and adjusted EBITDA increased due to higher fertilizer net selling prices, increased upstream fertilizer sales volumes and higher Retail earnings. Net earnings for the fourth quarter of 2025 were positively impacted by the gain on sale of investment related to the disposal of our 50 percent equity ownership in Profertil.





    Segment Results

    Our discussion of segment results set out on the following pages is a comparison of the results for the three and twelve months ended December 31, 2025 to the results for the three and twelve months ended December 31, 2024, unless otherwise noted.

    Retail

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    ($ millions, except as otherwise noted)

    2025

    2024

    % Change

     

    2025

    2024

    % Change

    Sales

    3,144

    3,179

    (1)

     

    17,620

    17,832

    (1)

    Cost of goods sold

    2,167

    2,193

    (1)

     

    13,017

    13,211

    (1)

    Gross margin

    977

    986

    (1)

     

    4,603

    4,621

    ‐

    Adjusted EBITDA 1

    311

    340

    (9)

     

    1,736

    1,696

    2

    1 See Note 2 to the interim financial statements.

    • Retail adjusted EBITDA decreased in the fourth quarter as the prior period benefited from other income items, most notably a $25 million gain on sale of land in Argentina. Adjusted EBITDA increased for the full year of 2025 due to lower operating expenses from our cost savings initiatives, higher proprietary products gross margin and strategic actions related to our Brazil margin improvement plan.

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

     

    Sales

     

    Gross Margin

     

    Sales

     

    Gross Margin

    ($ millions)

    2025

    2024

     

    2025

    2024

     

    2025

    2024

     

    2025

    2024

    Crop nutrients

    1,512

    1,528

     

    288

    294

     

    7,285

    7,211

     

    1,424

    1,444

    Crop protection products

    931

    948

     

    324

    351

     

    6,105

    6,313

     

    1,590

    1,622

    Seed

    162

    184

     

    48

    52

     

    2,128

    2,235

     

    408

    431

    Services and other

    254

    228

     

    219

    188

     

    944

    918

     

    750

    716

    Merchandise

    226

    230

     

    39

    40

     

    875

    897

     

    148

    150

    Nutrien Financial

    82

    77

     

    82

    77

     

    376

    361

     

    376

    361

    Nutrien Financial elimination 1

    (23)

    (16)

     

    (23)

    (16)

     

    (93)

    (103)

     

    (93)

    (103)

    Total

    3,144

    3,179

     

    977

    986

     

    17,620

    17,832

     

    4,603

    4,621

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    • Crop nutrients sales and gross margin decreased in the fourth quarter of 2025 due to lower sales volumes from a weather-shortened fall application window in the US and reduced demand for phosphate, partially offset by higher proprietary products gross margin. For the full year of 2025, sales increased due to higher selling prices, and gross margin was impacted by product mix shifts in North America and reduced demand in the fourth quarter. International crop nutrient sales volumes were lower in the fourth quarter and full year of 2025 mainly due to strategic actions in South America.
    • Crop protection products sales and gross margin were lower in the fourth quarter and full year of 2025 due to product mix shifts in North America and dry conditions in Australia, partially offset by higher proprietary products gross margin.
    • Seed sales and gross margin decreased in the fourth quarter due to strategic actions in South America. Sales and gross margin were lower for the full year of 2025 due to weather related impacts in the Southern US leading to fewer planted acres which impacted proprietary products gross margin.

    Supplemental Data

    Three Months Ended December 31

     

    Twelve Months Ended December 31

     

    Gross Margin

     

    % of Product Line 1

     

    Gross Margin

     

    % of Product Line 1

    ($ millions, except as otherwise noted)

    2025

    2024

     

    2025

    2024

     

    2025

    2024

     

    2025

    2024

    Proprietary products

     

     

     

     

     

     

     

     

     

     

     

    Crop nutrients

    65

    60

     

    22

    19

     

    450

    421

     

    32

    29

    Crop protection products

    43

    41

     

    13

    11

     

    503

    470

     

    32

    29

    Seed

    7

    6

     

    18

    16

     

    137

    154

     

    34

    36

    Merchandise

    4

    4

     

    9

    9

     

    14

    15

     

    9

    10

    Total

    119

    111

     

    12

    11

     

    1,104

    1,060

     

    24

    23

    1 Represents percentage of proprietary product margins over total product line gross margin.

    Three Months Ended December 31

     

    Twelve Months Ended December 31

     

    Sales Volumes

    (tonnes - thousands)

     

    Gross Margin / Tonne

    (dollars)

     

    Sales Volumes

    (tonnes - thousands)

     

    Gross Margin / Tonne

    (dollars)

     

    2025

    2024

     

    2025

    2024

     

    2025

    2024

     

    2025

    2024

    Crop nutrients

     

     

     

     

     

     

     

     

     

     

     

    North America

    1,600

    1,854

     

    137

    125

     

    8,502

    8,547

     

    143

    142

    International

    626

    716

     

    108

    87

     

    3,358

    3,715

     

    61

    62

    Total

    2,226

    2,570

     

    129

    114

     

    11,860

    12,262

     

    120

    118

     

    (percentages)

    December 31, 2025

     

    December 31, 2024

    Financial performance measures 1, 2

     

     

     

    Cash operating coverage ratio

    62

     

    63

    Average working capital to sales

    22

     

    20

    Average working capital to sales excluding Nutrien Financial

    1

     

    -

    Nutrien Financial adjusted net interest margin

    5.4

     

    5.3

    1 Rolling four quarters.

    2 These are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section.

    Potash

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    ($ millions, except as otherwise noted)

    2025

     

    2024

    % Change

     

    2025

     

    2024

    % Change

    Net sales

    736

     

    536

    37

     

    3,593

     

    2,989

    20

    Cost of goods sold

    324

     

    309

    5

     

    1,581

     

    1,448

    9

    Gross margin

    412

     

    227

    81

     

    2,012

     

    1,541

    31

    Adjusted EBITDA 1

    445

     

    291

    53

     

    2,254

     

    1,848

    22

    1 See Note 2 to the interim financial statements.

    • Potash adjusted EBITDA increased in the fourth quarter and full year of 2025 due to higher net selling prices and higher sales volumes, partially offset by higher provincial mining taxes. Total and offshore sales volumes in 2025 were the highest on record.

    Manufactured Product

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    North America

    726

     

    718

     

    4,638

     

    4,672

    Offshore

    2,077

     

    2,040

     

    9,615

     

    9,214

    Total sales volumes

    2,803

     

    2,758

     

    14,253

     

    13,886

    Net selling price

     

     

     

     

     

     

     

    North America

    305

     

    270

     

    286

     

    285

    Offshore

    247

     

    168

     

    235

     

    180

    Average net selling price

    262

     

    194

     

    252

     

    215

    Cost of goods sold

    115

     

    112

     

    111

     

    104

    Gross margin

    147

     

    82

     

    141

     

    111

    Depreciation and amortization

    45

     

    49

     

    46

     

    44

    Gross margin excluding depreciation and amortization 1

    192

     

    131

     

    187

     

    155

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    • Sales volumes were higher in the fourth quarter and full year of 2025 compared to the same periods in 2024. Higher offshore sales volumes were supported by strong potash affordability and underlying consumption growth in key offshore markets. North America sales volumes in the fourth quarter and full year of 2025 were consistent to the same periods in 2024.
    • Net selling price per tonne increased in the fourth quarter and full year of 2025 due to higher global benchmark prices.
    • Cost of goods sold per tonne increased in the fourth quarter and full year of 2025 primarily due to higher royalties and maintenance costs, with the full year also impacted by higher depreciation.

    Supplemental Data

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

     

    2025

     

    2024

     

    2025

     

    2024

    Production volumes (tonnes – thousands)

    3,539

     

    3,369

     

    13,966

     

    14,205

    Potash controllable cash cost of product manufactured per tonne 1

    61

     

    59

     

    58

     

    54

    Canpotex sales by market (percentage of sales volumes) 2

     

     

     

     

     

     

     

    Latin America

    35

     

    35

     

    39

     

    40

    Other Asian markets 3

    26

     

    24

     

    29

     

    28

    China

    13

     

    16

     

    11

     

    13

    India

    11

     

    11

     

    6

     

    7

    Other markets

    15

     

    14

     

    15

     

    12

    Total

    100

     

    100

     

    100

     

    100

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 See Note 10 to the interim financial statements.

    3 All Asian markets except China and India.

    Nitrogen

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    ($ millions, except as otherwise noted)

    2025

     

    20241,2

    % Change

     

    2025

     

    20241,2

    % Change

    Net sales

    1,093

     

    981

    11

     

    4,187

     

    3,576

    17

    Cost of goods sold

    682

     

    669

    2

     

    2,580

     

    2,374

    9

    Gross margin

    411

     

    312

    32

     

    1,607

     

    1,202

    34

    Adjusted EBITDA 2

    521

     

    471

    11

     

    2,147

     

    1,880

    14

    1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    2 See Note 2 to the interim financial statements.

    • Nitrogen adjusted EBITDA increased in the fourth quarter and the full year of 2025 due to higher net selling prices, partially offset by lower equity earnings from Profertil. Adjusted EBITDA for the full year of 2024 benefitted from insurance recoveries. Total ammonia production increased in 2025, supported by a four-percentage-point improvement in ammonia operating rate as we advanced reliability initiatives across our North American plants and completed low-cost debottlenecks at Redwater and Geismar.

    Manufactured Product

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    Ammonia

    546

     

    701

     

    2,420

     

    2,483

    Urea and ESN®

    656

     

    888

     

    3,099

     

    3,188

    Solutions, nitrates and sulfates

    1,373

     

    1,325

     

    5,369

     

    5,023

    Total sales volumes

    2,575

     

    2,914

     

    10,888

     

    10,694

    Net selling price

     

     

     

     

     

     

     

    Ammonia

    470

     

    448

     

    422

     

    410

    Urea and ESN®

    505

     

    403

     

    490

     

    421

    Solutions, nitrates and sulfates

    272

     

    213

     

    268

     

    221

    Average net selling price

    373

     

    327

     

    365

     

    324

    Cost of goods sold

    214

     

    221

     

    219

     

    213

    Gross margin

    159

     

    106

     

    146

     

    111

    Depreciation and amortization

    59

     

    58

     

    57

     

    55

    Gross margin excluding depreciation and amortization 1

    218

     

    164

     

    203

     

    166

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     
    • Sales volumes decreased in the fourth quarter of 2025 due to the previously announced controlled shutdown of our Trinidad facility on October 23, 2025 and planned turnarounds at our North American operations. Sales volumes increased for the full year of 2025 due to higher production from reliability improvements and low-cost debottlenecks that increased the availability of upgraded products.
    • Net selling price per tonne was higher in the fourth quarter and full year of 2025 for all major nitrogen products due to stronger benchmark prices.
    • Cost of goods sold per tonne decreased in the fourth quarter of 2025 due to a higher percentage of sales coming from our low-cost North American nitrogen plants. For the full year of 2025, cost of goods sold per tonne increased compared to the prior year due to higher natural gas costs, mainly driven by Henry Hub benchmark.

    Supplemental Data

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

     

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes – thousands)

     

     

     

     

     

     

     

    Fertilizer

    1,545

     

    1,801

     

    6,425

     

    6,259

    Industrial and feed

    1,030

     

    1,113

     

    4,463

     

    4,435

    Production volumes (tonnes – thousands)

     

     

     

     

     

     

     

    Ammonia production – total 1

    1,192

     

    1,451

     

    5,706

     

    5,608

    Ammonia production – adjusted 1, 2

    1,004

     

    1,041

     

    4,135

     

    3,953

    Ammonia operating rate (%) 2

    89

     

    92

     

    92

     

    88

    Natural gas costs (dollars per MMBtu)

     

     

     

     

     

     

     

    Overall natural gas cost excluding realized derivative impact

    3.31

     

    3.56

     

    3.53

     

    3.15

    Realized derivative impact 3

    ‐

     

    0.10

     

    ‐

     

    0.09

    Overall natural gas cost

    3.31

     

    3.66

     

    3.53

     

    3.24

    1 All figures are provided on a gross production basis in thousands of product tonnes.

    2 Excludes Trinidad and Joffre.

    3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses. Refer to Note 4 to the interim financial statements.

    Phosphate

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    ($ millions, except as otherwise noted)

    2025

     

    2024

    % Change

     

    2025

     

    2024

    % Change

    Net sales

    483

     

    414

    17

     

    1,734

     

    1,657

    5

    Cost of goods sold

    430

     

    394

    9

     

    1,590

     

    1,510

    5

    Gross margin

    53

     

    20

    165

     

    144

     

    147

    (2)

    Adjusted EBITDA 1

    107

     

    86

    24

     

    382

     

    384

    (1)

    1 See Note 2 to the interim financial statements.

    • Phosphate adjusted EBITDA increased in the fourth quarter of 2025 due to higher net selling prices and sales volumes, partially offset by higher sulfur input costs. Adjusted EBITDA slightly decreased for the full year of 2025 due to higher sulfur input costs and lower sales volumes, partially offset by higher net selling prices.

    Manufactured Product

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    ($ per tonne, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Sales volumes (tonnes - thousands)

     

     

     

     

     

     

     

    Fertilizer

    468

     

    435

     

    1,646

     

    1,751

    Industrial and feed

    186

     

    173

     

    717

     

    683

    Total sales volumes

    654

     

    608

     

    2,363

     

    2,434

    Net selling price

     

     

     

     

     

     

     

    Fertilizer

    677

     

    615

     

    677

     

    612

    Industrial and feed

    875

     

    812

     

    835

     

    822

    Average net selling price

    733

     

    671

     

    725

     

    671

    Cost of goods sold

    646

     

    631

     

    657

     

    603

    Gross margin

    87

     

    40

     

    68

     

    68

    Depreciation and amortization

    112

     

    127

     

    121

     

    119

    Gross margin excluding depreciation and amortization 1

    199

     

    167

     

    189

     

    187

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

     
    • Sales volumes were higher in the fourth quarter of 2025 due to higher production from reliability improvements and weather-related events that impacted the fourth quarter of 2024 production volumes, partially offset by reduced demand for phosphate. Sales volumes were lower for the full year due to lower production volumes in the first quarter of 2025.
    • Net selling price per tonne increased in the fourth quarter and full year of 2025 due to the strength of fertilizer benchmark prices.
    • Cost of goods sold per tonne increased in the fourth quarter and full year of 2025 primarily due to higher sulfur input costs.

    Supplemental Data

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

     

    2025

     

    2024

     

    2025

     

    2024

    Production volumes (P2O5 tonnes – thousands)

    367

     

    319

     

    1,360

     

    1,327

    P2O5 operating rate (%)

    86

     

    75

     

    80

     

    78

     
     

    Corporate and Others and Eliminations

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    ($ millions, except as otherwise noted)

    2025

     

    20241, 2

     

    % Change

     

    2025

     

    20241, 2

     

    % Change

    Corporate and Others

     

     

     

     

     

     

     

     

     

     

     

    Gross margin 2

    7

     

    14

     

    (50)

     

    27

     

    21

     

    29

    Selling expenses (recovery)

    5

     

    8

     

    (38)

     

    (1)

     

    2

     

    n/m

    General and administrative expenses

    106

     

    126

     

    (16)

     

    392

     

    405

     

    (3)

    Share-based compensation expense

    44

     

    20

     

    120

     

    163

     

    37

     

    341

    Foreign exchange (gain) loss, net of related derivatives

    (9)

     

    1

     

    n/m

     

    9

     

    360

     

    (98)

    Gain on sale of investment in Profertil 3

    (301)

     

    ‐

     

    ‐

     

    (301)

     

    ‐

     

    ‐

    Other expenses

    111

     

    105

     

    6

     

    207

     

    379

     

    (45)

    Adjusted EBITDA 2

    (133)

     

    (160)

     

    (17)

     

    (427)

     

    (452)

     

    (6)

    Eliminations

     

     

     

     

     

     

     

     

     

     

     

    Gross margin

    28

     

    22

     

    27

     

    (46)

     

    (2)

     

    n/m

    Adjusted EBITDA 2

    26

     

    27

     

    (4)

     

    (46)

     

    (1)

     

    n/m

    1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    2 See Note 2 to the interim financial statements.

    3 See Note 6 to the interim financial statements.

     
    • Share-based compensation expense was higher in the fourth quarter and full year of 2025 due to an increase in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors, such as our share price movement, our performance relative to our peer group and our return on invested capital.
    • Foreign exchange (gain) loss, net of related derivatives was lower in the full year of 2025 due to a lower loss on foreign currency derivatives in Brazil and lower foreign exchange losses primarily from our South American Retail region.
    • Gain on sale of investment was higher in the fourth quarter and full year of 2025 due to the sale of our 50 percent equity ownership in Profertil.
    • Other expenses was lower in the full year of 2025 as the comparable period of 2024 included a higher expense for asset retirement obligations related to our non-operating sites.





    Finance Costs, Income Taxes and Other Comprehensive (Loss) Income

     

    Three Months Ended December 31

     

    Twelve Months Ended December 31

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Finance costs

    183

     

    195

     

    (6)

     

    687

     

    720

     

    (5)

    Income taxes

     

     

     

     

     

     

     

     

     

     

     

    Income tax expense

    158

     

    84

     

    88

     

    752

     

    436

     

    72

    Actual effective tax rate including discrete items (%)

    22

     

    42

     

    (48)

     

    25

     

    38

     

    (34)

    Other comprehensive income (loss)

    33

     

    (298)

     

    n/m

     

    224

     

    (234)

     

    n/m

    • Income tax expense increased in the fourth quarter and full year of 2025 mainly due to higher earnings. The decrease in the actual effective tax rate for the three months ended December 31, 2025 is mainly due to the tax impact of the gain on sale of investment in Profertil. The decrease in the actual effective tax rate for the full year of 2025 is mainly due to lower non-recognizable losses in South America compared to the same period in 2024.
    • Other comprehensive income (loss) increased in the fourth quarter and full year of 2025 mainly due to the appreciation of the Australian, Brazilian and Canadian currencies, relative to the US dollar, compared to losses for the same periods in 2024.





    Forward-Looking Statements

    Certain statements and other information included in this document, including within the "Market Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "project", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien's business strategies, plans, prospects and opportunities; Nutrien's 2026 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; expectations regarding our capital allocation intentions and strategies including our intentions with respect to our strategic actions, including the review of strategic alternatives for our Phosphate business and the controlled shutdown of our Trinidad Nitrogen facility and options for our Trinidad operations and expectations related thereto, including the expected timing for strategic decisions in respect thereof; our expectations regarding Nutrien's strategic priorities and our ability to advance and achieve such strategic priorities in 2026 and beyond; expectations regarding various performance targets in 2026 and beyond and our ability to achieve those; capital spending expectations for 2026 and beyond; expectations regarding performance of our operating segments in 2026 and beyond; the expectation that internally generated cash flow, supplemented by available borrowings, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements; expectations regarding payment of dividends and share repurchases; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, including the expected impact of supply availability on global shipments of phosphate fertilizer and the expected impact of affordability on demand, crop input demand, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix, including the need to replenish soil nutrient levels, input costs, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates and the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, operating rates, inventories, crop development and natural gas curtailments; the negotiation of sales contracts; expected grower margins; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to generate free cash flow and deliver long-term returns to shareholders.

    These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

    All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

    The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives that we will conduct our operations and achieve results of operations as anticipated; growth in crop nutrient sales volumes; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and realize the expected synergies on the anticipated timeline or at all; increased proprietary products gross margin; successful execution of margin improvement plan in Brazil; a return to historical average crop protection product margin percentages; continued reliability improvements; sustained operating rates in Phosphate and Nitrogen; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, government support, crop development and cost of labor and interest, exchange and effective tax rates; potash demand growth in offshore markets; global economic conditions and the accuracy of our market outlook expectations for 2026 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

    Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets; failure to complete announced and future strategic and asset optimization initiatives, acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality of our business; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, or other changes to international trade arrangements; the results of our review of strategic alternative for our Phosphate business, including the process and the timing thereof, and whether the review will result in Nutrien undertaking a transaction, including the terms and timing relating thereto, the completion thereof and realizing benefits resulting therefrom; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

    The purpose of our Retail adjusted EBITDA, depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

    The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.





    Terms and Definitions

    For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms and definitions" section of our 2024 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.





    About Nutrien

    Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve farmers. Our vision is to be the leading global agricultural solutions provider, delivering superior shareholder value through safe and sustainable operations. To achieve this vision, our strategy is anchored in three priorities: simplify and focus, operational excellence and a disciplined and intentional approach to capital allocation. This strategy is designed to create low-risk, structural free cash flow growth by leveraging our core competencies and to deliver reliable, growing cash returns to shareholders.

    More information about Nutrien can be found at www.nutrien.com.

    Selected financial data for download can be found in our data tool at https://www.nutrien.com/investors/interactive-data-tool

    Such data is not incorporated by reference herein.

    Nutrien will host a Conference Call on Thursday, February 19, 2026 at 10:00 a.m. Eastern Time.

    Telephone conference dial-in numbers:

    • From Canada and the US: 1-800-990-2777
    • International: 1-416-855-9085
    • Conference ID: 93473. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

    Live Audio Webcast: Visit https://www.nutrien.com/news/events/2025-q4-earnings-conference-call





    Non-GAAP Financial Measures

    We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

    These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

    The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

    Adjusted EBITDA (Consolidated)

    Most directly comparable IFRS financial measure: Net earnings (loss).

    Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, asset retirement obligations ("ARO") and accrued environmental costs ("ERL") related to our non-operating sites, and loss related to financial instruments in Argentina.

    Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

     

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Net earnings

    580

     

    118

     

    2,297

     

    700

    Finance costs

    183

     

    195

     

    687

     

    720

    Income tax expense

    158

     

    84

     

    752

     

    436

    Depreciation and amortization

    567

     

    590

     

    2,369

     

    2,339

    EBITDA 1

    1,488

     

    987

     

    6,105

     

    4,195

    Adjustments:

     

     

     

     

     

     

     

    Share-based compensation expense

    44

     

    20

     

    163

     

    37

    Foreign exchange (gain) loss, net of related derivatives

    (9)

     

    1

     

    9

     

    360

    ARO/ERL related expenses (income) for non-operating sites

    9

     

    (1)

     

    2

     

    151

    Loss related to financial instruments in Argentina

    ‐

     

    1

     

    ‐

     

    35

    Restructuring costs

    46

     

    47

     

    68

     

    47

    Impairment of assets

    ‐

     

    ‐

     

    ‐

     

    530

    Gain on sale of investment in Profertil

    (301)

     

    ‐

     

    (301)

     

    ‐

    Adjusted EBITDA

    1,277

     

    1,055

     

    6,046

     

    5,355

    1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

     
     

    Adjusted Net Earnings and Adjusted Net Earnings Per Share

    Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

    Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

     

    Three Months Ended

    December 31, 2025

     

    Twelve Months Ended

    December 31, 2025

     

     

     

     

     

    Per

     

     

     

     

     

    Per

     

    Increases

     

     

     

    Diluted

     

    Increases

     

     

     

    Diluted

    ($ millions, except as otherwise noted)

    (Decreases)

     

    Post-Tax

     

    Share

     

    (Decreases)

     

    Post-Tax

     

    Share

    Net earnings attributable to equity holders of Nutrien

     

     

    571

     

    1.18

     

     

     

    2,267

     

    4.66

    Adjustments:

     

     

     

     

     

     

     

     

     

     

     

    Share-based compensation expense

    44

     

    33

     

    0.07

     

    163

     

    123

     

    0.25

    Foreign exchange (gain) loss, net of related derivatives

    (9)

     

    (8)

     

    (0.02)

     

    9

     

    6

     

    0.03

    Restructuring costs

    46

     

    41

     

    0.09

     

    68

     

    59

     

    0.12

    ARO/ERL related expenses for non-operating sites

    9

     

    7

     

    0.01

     

    2

     

    2

     

    ‐

    Gain on sale of investment in Profertil

    (301)

     

    (241)

     

    (0.50)

     

    (301)

     

    (241)

     

    (0.50)

    Sub-total adjustments

    (211)

     

    (168)

     

    (0.35)

     

    (59)

     

    (51)

     

    (0.10)

    Adjusted net earnings

     

     

    403

     

    0.83

     

     

     

    2,216

     

    4.56

     

     

    Three Months Ended

    December 31, 2024

     

    Twelve Months Ended

    December 31, 2024

     

     

     

     

     

    Per

     

     

     

     

     

    Per

     

    Increases

     

     

     

    Diluted

     

    Increases

     

     

     

    Diluted

    ($ millions, except as otherwise noted)

    (Decreases)

     

    Post-Tax

     

    Share

     

    (Decreases)

     

    Post-Tax

     

    Share

    Net earnings attributable to equity holders of Nutrien

     

     

    113

     

    0.23

     

     

     

    674

     

    1.36

    Adjustments:

     

     

     

     

     

     

     

     

     

     

     

    Share-based compensation expense

    20

     

    15

     

    0.03

     

    37

     

    27

     

    0.05

    Foreign exchange loss (gain), net of related derivatives

    1

     

    (16)

     

    (0.03)

     

    360

     

    346

     

    0.70

    Restructuring costs

    47

     

    38

     

    0.08

     

    47

     

    38

     

    0.08

    Impairment of assets

    ‐

     

    ‐

     

    ‐

     

    530

     

    492

     

    1.00

    ARO/ERL related (income) expenses for non-operating sites

    (1)

     

    (1)

     

    ‐

     

    151

     

    106

     

    0.21

    Loss related to financial instruments in Argentina

    1

     

    1

     

    ‐

     

    35

     

    35

     

    0.07

    Sub-total adjustments

    68

     

    37

     

    0.08

     

    1,160

     

    1,044

     

    2.11

    Adjusted net earnings

     

     

    150

     

    0.31

     

     

     

    1,718

     

    3.47

     
     

    Effective Tax Rate on Adjusted Net Earnings

    Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

    Effective tax rate on adjusted net earnings is calculated as adjusted income tax expense divided by adjusted earnings before income taxes. We use this measure to provide the actual result for a previously disclosed forward-looking effective tax rate on adjusted net earnings guidance.

    ($ millions, except as otherwise noted)

     

    2025

    Earnings before income taxes

     

    3,049

    Adjustments 1

     

    (59)

    Adjusted earnings before income taxes

     

    2,990

     

     

     

    Income tax expense

     

    752

    Adjustments 2

     

    (8)

    Adjusted income tax expense

     

    744

     

     

     

    Effective tax rate on adjusted net earnings (%)

     

    24.9

    1 Calculated as sum of pre-tax adjustments noted in the Adjusted Net Earnings section.

    2 Calculated as difference between the sum of pre-tax and post-tax adjustments noted in the Adjusted Net Earnings section.

     

    Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

    Most directly comparable IFRS financial measure: Gross margin.

    Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the "Segment Results" section.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

    Potash Controllable Cash Cost of Product Manufactured ("COPM") Per Tonne

    Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

    Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

    Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

     

    Three Months Ended

    December 31

     

    Twelve Months Ended

    December 31

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Total COGS – Potash

    324

     

    309

     

    1,581

     

    1,448

    Change in inventory

    94

     

    66

     

    (2)

     

    36

    Other adjustments 1

    (7)

     

    (7)

     

    (27)

     

    (21)

    COPM

    411

     

    368

     

    1,552

     

    1,463

    Depreciation and amortization in COPM

    (157)

     

    (142)

     

    (606)

     

    (581)

    Royalties in COPM

    (25)

     

    (17)

     

    (93)

     

    (79)

    Natural gas costs and carbon taxes in COPM

    (12)

     

    (9)

     

    (42)

     

    (36)

    Controllable cash COPM

    217

     

    200

     

    811

     

    767

    Production volumes (tonnes – thousands)

    3,539

     

    3,369

     

    13,966

     

    14,205

    Potash controllable cash COPM per tonne

    61

     

    59

     

    58

     

    54

    1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

     

    Nutrien Financial Adjusted Net Interest Margin

    Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: Used by credit rating agencies and others to evaluate the financial performance of Nutrien Financial.

     

    Rolling Four Quarters Ended December 31, 2025

    ($ millions, except as otherwise noted)

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Q4 2025

     

    Total/Average

    Nutrien Financial revenue

    70

     

    135

     

    89

     

    82

     

     

    Deemed interest expense 1

    (29)

     

    (49)

     

    (52)

     

    (47)

     

     

    Net interest

    41

     

    86

     

    37

     

    35

     

    199

     

     

     

     

     

     

     

     

     

     

    Average Nutrien Financial net receivables

    2,569

     

    4,645

     

    4,452

     

    3,106

     

    3,693

    Nutrien Financial adjusted net interest margin (%)

     

     

     

     

     

     

     

     

    5.4

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Total/Average

    Nutrien Financial revenue

    66

     

    133

     

    85

     

    77

     

     

    Deemed interest expense 1

    (27)

     

    (50)

     

    (52)

     

    (45)

     

     

    Net interest

    39

     

    83

     

    33

     

    32

     

    187

     

     

     

     

     

     

     

     

     

     

    Average Nutrien Financial net receivables

    2,489

     

    4,560

     

    4,318

     

    2,877

     

    3,561

    Nutrien Financial adjusted net interest margin (%)

     

     

     

     

     

     

     

     

    5.3

    1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

     

    Retail Cash Operating Coverage Ratio

    Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

     

    Rolling Four Quarters Ended December 31, 2025

    ($ millions, except as otherwise noted)

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Q4 2025

     

    Total

    Selling expenses

    755

     

    948

     

    792

     

    811

     

    3,306

    General and administrative expenses

    44

     

    44

     

    44

     

    40

     

    172

    Other (income) expenses

    25

     

    54

     

    40

     

    4

     

    123

    Operating expenses

    824

     

    1,046

     

    876

     

    855

     

    3,601

    Depreciation and amortization in operating expenses

    (179)

     

    (172)

     

    (179)

     

    (184)

     

    (714)

    Operating expenses excluding depreciation and amortization

    645

     

    874

     

    697

     

    671

     

    2,887

     

     

     

     

     

     

     

     

     

     

    Gross margin

    686

     

    2,018

     

    922

     

    977

     

    4,603

    Depreciation and amortization in cost of goods sold

    5

     

    5

     

    5

     

    5

     

    20

    Gross margin excluding depreciation and amortization

    691

     

    2,023

     

    927

     

    982

     

    4,623

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    62

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Total

    Selling expenses

    790

     

    1,005

     

    815

     

    808

     

    3,418

    General and administrative expenses

    52

     

    51

     

    51

     

    37

     

    191

    Other expenses (income)

    22

     

    41

     

    32

     

    (8)

     

    87

    Operating expenses

    864

     

    1,097

     

    898

     

    837

     

    3,696

    Depreciation and amortization in operating expenses

    (190)

     

    (193)

     

    (182)

     

    (186)

     

    (751)

    Operating expenses excluding depreciation and amortization

    674

     

    904

     

    716

     

    651

     

    2,945

     

     

     

     

     

     

     

     

     

     

    Gross margin

    747

     

    2,029

     

    859

     

    986

     

    4,621

    Depreciation and amortization in cost of goods sold

    4

     

    3

     

    8

     

    5

     

    20

    Gross margin excluding depreciation and amortization

    751

     

    2,032

     

    867

     

    991

     

    4,641

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    63

     

    Retail Average Working Capital to Sales and Retail Average Working Capital to Sales Excluding Nutrien Financial

    Definition: Retail average working capital divided by Retail sales for the last four rolling quarters. We also look at this metric excluding Nutrien Financial revenue and working capital.

    Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

     

    Rolling Four Quarters Ended December 31, 2025

    ($ millions, except as otherwise noted)

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Q4 2025

     

    Average/Total

    Current assets

    11,510

     

    11,442

     

    10,823

     

    11,185

     

     

    Current liabilities

    (7,561)

     

    (8,051)

     

    (5,348)

     

    (8,275)

     

     

    Working capital

    3,949

     

    3,391

     

    5,475

     

    2,910

     

    3,931

    Nutrien Financial working capital

    (2,569)

     

    (4,645)

     

    (4,452)

     

    (3,106)

     

     

    Working capital excluding Nutrien Financial

    1,380

     

    (1,254)

     

    1,023

     

    (196)

     

    238

     

     

     

     

     

     

     

     

     

     

    Sales

    3,090

     

    7,959

     

    3,427

     

    3,144

     

    17,620

    Nutrien Financial revenue

    (70)

     

    (135)

     

    (89)

     

    (82)

     

     

    Sales excluding Nutrien Financial

    3,020

     

    7,824

     

    3,338

     

    3,062

     

    17,244

     

     

     

     

     

     

     

     

     

     

    Average working capital to sales (%)

     

     

     

     

     

     

     

     

    22

    Average working capital to sales excluding Nutrien Financial (%)

     

     

     

    1

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2024

    ($ millions, except as otherwise noted)

    Q1 2024

     

    Q2 2024

     

    Q3 2024

     

    Q4 2024

     

    Average/Total

    Current assets

    11,821

     

    11,181

     

    10,559

     

    10,360

     

     

    Current liabilities

    (8,401)

     

    (8,002)

     

    (5,263)

     

    (8,028)

     

     

    Working capital

    3,420

     

    3,179

     

    5,296

     

    2,332

     

    3,557

    Nutrien Financial working capital

    (2,489)

     

    (4,560)

     

    (4,318)

     

    (2,877)

     

     

    Working capital excluding Nutrien Financial

    931

     

    (1,381)

     

    978

     

    (545)

     

    (4)

     

     

     

     

     

     

     

     

     

     

    Sales

    3,308

     

    8,074

     

    3,271

     

    3,179

     

    17,832

    Nutrien Financial revenue

    (66)

     

    (133)

     

    (85)

     

    (77)

     

     

    Sales excluding Nutrien Financial

    3,242

     

    7,941

     

    3,186

     

    3,102

     

    17,471

     

     

     

     

     

     

     

     

     

     

    Average working capital to sales (%)

     

     

     

     

     

     

     

     

    20

    Average working capital to sales excluding Nutrien Financial (%)

     

     

     

    ‐

     
     

    Other Financial Measures

    Selected Additional Financial Data

    Nutrien Financial

    As at December 31, 2025

    As at

    December 31, 2024

    ($ millions)

    Current

    <31 Days

    past due

    31–90 Days

    past due

    >90 Days

    past due

    Gross receivables

    Allowance 1

    Net

    receivables 2

    Net

    receivables

    North America

    1,831

    260

    110

    181

    2,382

    (50)

    2,332

    2,178

    International

    647

    82

    21

    31

    781

    (7)

    774

    699

    Nutrien Financial

    receivables

    2,478

    342

    131

    212

    3,163

    (57)

    3,106

    2,877

    1 Bad debt expense on the above receivables for the twelve months ended December 31, 2025 was $46 million, in the Retail segment.

    2 In 2025, we assume a debt-to-equity ratio of 9:1 (2024 – 7:1) in funding Nutrien Financial receivables, based on the underlying credit quality of the assets.

     
     

    Supplementary Financial Measures

    Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

    The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

    Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

    Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures exclude capital outlays for business acquisitions and equity-accounted investees.

    Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

    Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien's shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of cash to shareholders.





    Condensed Consolidated Financial Statements

    Unaudited

    Condensed Consolidated Statements of Earnings

     

     

    Three Months Ended

     

    Twelve Months Ended

     

     

    December 31

     

    December 31

    ($ millions, except as otherwise noted)

    Note

    2025

     

    2024

     

    2025

     

    2024

    Sales

    2, 10

    5,340

     

    5,079

     

    26,885

     

    25,972

    Freight, transportation and distribution

     

    198

     

    215

     

    936

     

    956

    Cost of goods sold

     

    3,254

     

    3,283

     

    17,602

     

    17,486

    Gross Margin

     

    1,888

     

    1,581

     

    8,347

     

    7,530

    Selling expenses

     

    817

     

    813

     

    3,320

     

    3,435

    General and administrative expenses

     

    156

     

    176

     

    600

     

    644

    Provincial mining taxes

     

    83

     

    45

     

    372

     

    255

    Share-based compensation expense

     

    44

     

    20

     

    163

     

    37

    Impairment of assets

    3

    ‐

     

    ‐

     

    ‐

     

    530

    Foreign exchange (gain) loss, net of related derivatives

    7

    (9)

     

    1

     

    9

     

    360

    Gain on sale of investment in Profertil

    6

    (301)

     

    ‐

     

    (301)

     

    ‐

    Other expenses

    4

    177

     

    129

     

    448

     

    413

    Earnings Before Finance Costs and Income Taxes

    921

     

    397

     

    3,736

     

    1,856

    Finance costs

     

    183

     

    195

     

    687

     

    720

    Earnings Before Income Taxes

     

    738

     

    202

     

    3,049

     

    1,136

    Income tax expense

    5

    158

     

    84

     

    752

     

    436

    Net Earnings

     

    580

     

    118

     

    2,297

     

    700

    Attributable to

     

     

     

     

     

     

     

     

    Equity holders of Nutrien

     

    571

     

    113

     

    2,267

     

    674

    Non-controlling interest

     

    9

     

    5

     

    30

     

    26

    Net Earnings

     

    580

     

    118

     

    2,297

     

    700

     

     

     

     

     

     

     

     

     

    Net Earnings Per Share Attributable to Equity Holders of Nutrien ("EPS")

    Basic

     

    1.18

     

    0.23

     

    4.66

     

    1.36

    Diluted

     

    1.18

     

    0.23

     

    4.66

     

    1.36

    Weighted average shares outstanding for basic EPS

     

    483,028,000

     

    492,843,000

     

    486,335,000

     

    494,198,000

    Weighted average shares outstanding for diluted EPS

     

    483,234,000

     

    492,930,000

     

    486,518,000

     

    494,365,000

     

     

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Condensed Consolidated Statements of Comprehensive Income (Loss)

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    ($ millions, net of related income taxes)

    2025

     

    2024

     

    2025

     

    2024

    Net Earnings

    580

     

    118

     

    2,297

     

    700

    Other comprehensive income (loss)

     

     

     

     

     

     

     

    Items that will not be reclassified to net earnings:

     

     

     

     

     

     

     

    Net actuarial gain on defined benefit plans

    6

     

    17

     

    6

     

    17

    Net fair value gain (loss) on investments

    ‐

     

    2

     

    (18)

     

    55

    Items that have been or may be subsequently reclassified to net earnings:

     

     

     

     

     

     

     

    Gain (loss) on currency translation of foreign operations

    16

     

    (282)

     

    212

     

    (254)

    Other

    11

     

    (35)

     

    24

     

    (52)

    Other Comprehensive Income (Loss)

    33

     

    (298)

     

    224

     

    (234)

    Comprehensive Income (Loss)

    613

     

    (180)

     

    2,521

     

    466

    Attributable to

     

     

     

     

     

     

     

    Equity holders of Nutrien

    604

     

    (182)

     

    2,490

     

    443

    Non-controlling interest

    9

     

    2

     

    31

     

    23

    Comprehensive Income (Loss)

    613

     

    (180)

     

    2,521

     

    466

     

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Condensed Consolidated Statements of Cash Flows

     

     

    Three Months Ended

     

    Twelve Months Ended

     

     

    December 31

     

    December 31

    ($ millions)

    Note

    2025

     

    2024

     

    2025

     

    2024

    Operating Activities

     

     

     

     

     

     

     

     

    Net earnings

     

    580

     

    118

     

    2,297

     

    700

    Adjustments for:

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

    567

     

    590

     

    2,369

     

    2,339

    Share-based compensation expense

     

    44

     

    20

     

    163

     

    37

    Impairment of assets

    3

    ‐

     

    ‐

     

    ‐

     

    530

    Gain on sale of investment in Profertil

    6

    (301)

     

    ‐

     

    (301)

     

    ‐

    Provision for deferred income tax

     

    23

     

    16

     

    250

     

    31

    Net (undistributed) distributed earnings of equity-accounted investees

     

    (1)

     

    (22)

     

    65

     

    (8)

    Loss related to financial instruments in Argentina

    4

    ‐

     

    1

     

    ‐

     

    35

    Long-term income tax receivables and payables

     

    (83)

     

    30

     

    (65)

     

    47

    Other long-term assets, liabilities and miscellaneous

     

    61

     

    (16)

     

    12

     

    311

    Cash from operations before working capital changes

     

    890

     

    737

     

    4,790

     

    4,022

    Changes in non-cash operating working capital:

     

     

     

     

     

     

     

     

    Receivables

     

    2,120

     

    2,170

     

    (128)

     

    (224)

    Inventories and prepaid expenses and other current assets

     

    (2,434)

     

    (2,205)

     

    (557)

     

    60

    Trade, other payables and accrued liabilities

     

    2,401

     

    2,421

     

    (98)

     

    (323)

    Cash Provided by Operating Activities

     

    2,977

     

    3,123

     

    4,007

     

    3,535

    Investing Activities

     

     

     

     

     

     

     

     

    Capital expenditures 1

     

    (751)

     

    (767)

     

    (2,005)

     

    (2,154)

    Business acquisitions, net of cash acquired

     

    (11)

     

    (15)

     

    (23)

     

    (21)

    Proceeds from (purchase of) investments, held within three months, net

     

    35

     

    74

     

    (33)

     

    44

    Purchase of investments

     

    (1)

     

    ‐

     

    (94)

     

    (112)

    Proceeds from sale of investments

    6

    416

     

    79

     

    838

     

    138

    Net changes in non-cash working capital

     

    61

     

    82

     

    6

     

    27

    Other

     

    ‐

     

    28

     

    (61)

     

    (55)

    Cash Used in Investing Activities

     

    (251)

     

    (519)

     

    (1,372)

     

    (2,133)

    Financing Activities

     

     

     

     

     

     

     

     

    Repayment of debt, maturing within three months, net

     

    (1,621)

     

    (1,231)

     

    (696)

     

    (142)

    Proceeds from debt

    8

    ‐

     

    24

     

    998

     

    1,022

    Repayment of debt

    8

    (527)

     

    (527)

     

    (1,089)

     

    (659)

    Repayment of principal portion of lease liabilities

     

    (106)

     

    (102)

     

    (419)

     

    (402)

    Dividends paid to Nutrien's shareholders

    9

    (263)

     

    (265)

     

    (1,061)

     

    (1,060)

    Repurchase of common shares

    9

    (150)

     

    (134)

     

    (551)

     

    (184)

    Issuance of common shares

     

    9

     

    2

     

    38

     

    18

    Other

     

    (3)

     

    (6)

     

    (37)

     

    (46)

    Cash Used in Financing Activities

     

    (2,661)

     

    (2,239)

     

    (2,817)

     

    (1,453)

    Effect of Exchange Rate Changes on Cash and Cash Equivalents

     

    12

     

    (32)

     

    30

     

    (37)

    Increase (Decrease) in Cash and Cash Equivalents

     

    77

     

    333

     

    (152)

     

    (88)

    Cash and Cash Equivalents – Beginning of Period

     

    624

     

    520

     

    853

     

    941

    Cash and Cash Equivalents – End of Period

     

    701

     

    853

     

    701

     

    853

    Cash and cash equivalents is composed of:

     

     

     

     

     

     

     

     

    Cash

     

    566

     

    741

     

    566

     

    741

    Short-term investments

     

    135

     

    112

     

    135

     

    112

     

     

    701

     

    853

     

    701

     

    853

    Supplemental Cash Flows Information

     

     

     

     

     

     

     

     

    Interest paid

     

    220

     

    244

     

    738

     

    740

    Income taxes paid

     

    134

     

    61

     

    335

     

    321

    Total cash outflow for leases

     

    144

     

    140

     

    567

     

    558

    1 Includes additions to property, plant and equipment, and intangible assets for the three months ended December 31, 2025 of $707 million and $44 million (2024 – $735 million and $32 million), respectively, and for the twelve months ended December 31, 2025 of $1,882 million and $123 million (2024 – $2,025 million and $129 million), respectively.

     

    (See Notes to the Condensed Consolidated Financial Statements)

     
     

    Condensed Consolidated Statements of Changes in Shareholders' Equity

     

     

     

     

     

     

     

    Accumulated other comprehensive

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (loss) income ("AOCI")

     

     

     

     

     

     

     

    ($ millions, inclusive of related tax, except as otherwise noted)

    Number of

    common

    shares

     

    Share

    capital

     

    Contributed

    surplus

     

    (Loss) gain

    on currency

    translation

    of foreign

    operations

     

    Other

     

    Total

    AOCI

     

    Retained

    earnings

     

    Equity

    holders

    of

    Nutrien

     

    Non-

    controlling

    interest

     

    Total

    equity

    Balance – December 31, 2023

    494,551,730

     

    13,838

     

    83

     

    (286)

     

    (10)

     

    (296)

     

    11,531

     

    25,156

     

    45

     

    25,201

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    674

     

    674

     

    26

     

    700

    Other comprehensive (loss) income

    ‐

     

    ‐

     

    ‐

     

    (251)

     

    20

     

    (231)

     

    ‐

     

    (231)

     

    (3)

     

    (234)

    Shares repurchased for cancellation (Note 9)

    (3,944,903)

     

    (110)

     

    (20)

     

    ‐

     

    ‐

     

    ‐

     

    (60)

     

    (190)

     

    ‐

     

    (190)

    Dividends declared 1

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (1,063)

     

    (1,063)

     

    ‐

     

    (1,063)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (33)

     

    (33)

    Effect of share-based compensation including issuance of common shares

    418,619

     

    20

     

    5

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    25

     

    ‐

     

    25

    Transfer of net gain on sale of investment

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    7

     

    7

     

    ‐

     

    7

    Transfer of net loss on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    29

     

    29

     

    ‐

     

    29

     

    ‐

     

    29

    Transfer of net actuarial gain on defined benefit plans

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (17)

     

    (17)

     

    17

     

    ‐

     

    ‐

     

    ‐

    Balance – December 31, 2024

    491,025,446

     

    13,748

     

    68

     

    (537)

     

    22

     

    (515)

     

    11,106

     

    24,407

     

    35

     

    24,442

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    2,267

     

    2,267

     

    30

     

    2,297

    Other comprehensive income

    ‐

     

    ‐

     

    ‐

     

    211

     

    12

     

    223

     

    ‐

     

    223

     

    1

     

    224

    Shares repurchased for cancellation (Note 9)

    (9,829,408)

     

    (275)

     

    (10)

     

    ‐

     

    ‐

     

    ‐

     

    (275)

     

    (560)

     

    ‐

     

    (560)

    Dividends declared 1

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (1,059)

     

    (1,059)

     

    ‐

     

    (1,059)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    1

     

    (24)

     

    (23)

    Effect of share-based compensation including issuance of common shares

    766,195

     

    46

     

    (1)

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    45

     

    ‐

     

    45

    Transfer of net gain on sale of investment

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (27)

     

    (27)

     

    27

     

    ‐

     

    ‐

     

    ‐

    Transfer of net gain on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (1)

     

    (1)

     

    ‐

     

    (1)

     

    ‐

     

    (1)

    Transfer of net actuarial gain on defined benefit plans

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (6)

     

    (6)

     

    6

     

    ‐

     

    ‐

     

    ‐

    Other

    ‐

     

    ‐

     

    ‐

     

    (3)

     

    ‐

     

    (3)

     

    3

     

    ‐

     

    ‐

     

    ‐

    Balance – December 31, 2025

    481,962,233

     

    13,519

     

    57

     

    (329)

     

    ‐

     

    (329)

     

    12,076

     

    25,323

     

    42

     

    25,365

    1 During the twelve months ended December 31, 2025, we declared dividends of $2.18 per share (2024 - $2.16 per share).

     

    (See Notes to the Condensed Consolidated Financial Statements)

     
     

    Condensed Consolidated Balance Sheets

     

     

    As at

     

    As at

     

     

    December 31

     

    December 31

    ($ millions)

    Note

    2025

     

    2024

    Assets

     

     

     

     

    Current assets

     

     

     

     

    Cash and cash equivalents

     

    701

     

    853

    Receivables

    10

    5,675

     

    5,390

    Inventories

     

    6,977

     

    6,148

    Prepaid expenses and other current assets

     

    1,396

     

    1,401

     

     

    14,749

     

    13,792

    Non-current assets

     

     

     

     

    Property, plant and equipment

    3

    22,747

     

    22,604

    Goodwill

    3

    12,136

     

    12,043

    Intangible assets

    3

    1,667

     

    1,819

    Investments

    6

    144

     

    698

    Other assets

     

    858

     

    884

    Total Assets

     

    52,301

     

    51,840

    Liabilities

     

     

     

     

    Current liabilities

     

     

     

     

    Short-term debt

     

    873

     

    1,534

    Current portion of long-term debt

    8

    513

     

    1,037

    Current portion of lease liabilities

     

    346

     

    356

    Trade, other payables and accrued liabilities

    10

    9,309

     

    9,118

     

     

    11,041

     

    12,045

    Non-current liabilities

     

     

     

     

    Long-term debt

    8

    9,350

     

    8,881

    Lease liabilities

     

    937

     

    999

    Deferred income tax liabilities

     

    3,666

     

    3,539

    Pension and other post-retirement benefit liabilities

     

    221

     

    227

    Asset retirement obligations and accrued environmental costs

     

    1,468

     

    1,543

    Other non-current liabilities

     

    253

     

    164

    Total Liabilities

     

    26,936

     

    27,398

    Shareholders' Equity

     

     

     

     

    Share capital

    9

    13,519

     

    13,748

    Contributed surplus

     

    57

     

    68

    Accumulated other comprehensive loss

     

    (329)

     

    (515)

    Retained earnings

     

    12,076

     

    11,106

    Equity holders of Nutrien

     

    25,323

     

    24,407

    Non-controlling interest

     

    42

     

    35

    Total Shareholders' Equity

     

    25,365

     

    24,442

    Total Liabilities and Shareholders' Equity

     

    52,301

     

    51,840

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

    Notes to the Condensed Consolidated Financial Statements

    As at and for the Three and Twelve Months Ended December 31, 2025

    Note 1 Basis of presentation

    Nutrien Ltd. (collectively with its subsidiaries, "Nutrien", "we", "us", "our" or "the Company") is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

    These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2024 annual audited consolidated financial statements. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2024 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

    Certain immaterial 2024 figures have been reclassified in Note 2 Segment information and Note 4 Other expenses (income).

    In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

    These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on February 18, 2026.

    Note 2 Segment information

    We have four reportable operating segments: Retail, Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, South America and Australia. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core businesses. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

    In the fourth quarter of 2025, the Chief Operating Decision Maker ("CODM") reassessed our product groupings and determined that the performance of our Purchase for Resale business should be evaluated as part of the Corporate and Others segment. It had previously been recorded in our Nitrogen segment. The Purchase for Resale business focuses primarily on sales to international customers. Purchased product that remains in upstream is primarily purchases of inventory to satisfy sales contracts that we cannot fulfill with our manufactured products. The CODM concluded this change was appropriate based on the nature and strategic alignment of purchase for resale activities. Comparative amounts for the Corporate and Others and Nitrogen segments were reclassified. As a result of the reclassification, the Corporate and Others segment reflected the following increases and the Nitrogen segment reflected the corresponding decreases for the three and twelve months ended December 31, 2024.

     

    Three Months Ended

    Twelve Months Ended

    ($ millions)

    December 31, 2024

    December 31, 2024

    Sales

    33

    173

    Gross Margin

    1

    8

    EBITDA

    1

    4

     

     

    Three Months Ended December 31, 2025

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    3,137

     

    686

     

    994

     

    478

     

    45

     

    ‐

     

    5,340

     

    – intersegment

    7

     

    106

     

    246

     

    65

     

    ‐

     

    (424)

     

    ‐

    Sales

    – total

    3,144

     

    792

     

    1,240

     

    543

     

    45

     

    (424)

     

    5,340

    Freight, transportation and distribution 1

    ‐

     

    56

     

    147

     

    60

     

    (1)

     

    (64)

     

    198

    Net sales

    3,144

     

    736

     

    1,093

     

    483

     

    46

     

    (360)

     

    5,142

    Cost of goods sold

    2,167

     

    324

     

    682

     

    430

     

    39

     

    (388)

     

    3,254

    Gross margin

    977

     

    412

     

    411

     

    53

     

    7

     

    28

     

    1,888

    Selling expenses (recovery)

    811

     

    2

     

    5

     

    1

     

    5

     

    (7)

     

    817

    General and administrative expenses

    40

     

    3

     

    4

     

    3

     

    106

     

    ‐

     

    156

    Provincial mining taxes

    ‐

     

    83

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    83

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    44

     

    ‐

     

    44

    Foreign exchange gain, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (9)

     

    ‐

     

    (9)

    Gain on sale of investment in Profertil

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (301)

     

    ‐

     

    (301)

    Other expenses

    4

     

    6

     

    32

     

    15

     

    111

     

    9

     

    177

    Earnings before finance costs and income taxes

    122

     

    318

     

    370

     

    34

     

    51

     

    26

     

    921

    Depreciation and amortization

    189

     

    127

     

    151

     

    73

     

    27

     

    ‐

     

    567

    EBITDA

    311

     

    445

     

    521

     

    107

     

    78

     

    26

     

    1,488

    Restructuring costs

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    46

     

    ‐

     

    46

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    44

     

    ‐

     

    44

    ARO/ERL related expenses for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    9

     

    ‐

     

    9

    Foreign exchange gain, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (9)

     

    ‐

     

    (9)

    Gain on sale of investment in Profertil

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (301)

     

    ‐

     

    (301)

    Adjusted EBITDA

    311

     

    445

     

    521

     

    107

     

    (133)

     

    26

     

    1,277

    1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

     

     

    Three Months Ended December 31, 2024

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

    Nitrogen1

     

    Phosphate

    and Others1

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    3,179

     

    522

    920

     

    403

    55

     

    ‐

     

    5,079

     

    – intersegment

    ‐

     

    65

    223

     

    68

    ‐

     

    (356)

     

    ‐

    Sales

    – total

    3,179

     

    587

    1,143

     

    471

    55

     

    (356)

     

    5,079

    Freight, transportation and distribution 2

    ‐

     

    51

    162

     

    57

    1

     

    (56)

     

    215

    Net sales

    3,179

     

    536

    981

     

    414

    54

     

    (300)

     

    4,864

    Cost of goods sold

    2,193

     

    309

    669

     

    394

    40

     

    (322)

     

    3,283

    Gross margin

    986

     

    227

    312

     

    20

    14

     

    22

     

    1,581

    Selling expenses (recovery)

    808

     

    1

    2

     

    1

    8

     

    (7)

     

    813

    General and administrative expenses

    37

     

    2

    8

     

    3

    126

     

    ‐

     

    176

    Provincial mining taxes

    ‐

     

    45

    ‐

     

    ‐

    ‐

     

    ‐

     

    45

    Share-based compensation expense

    ‐

     

    ‐

    ‐

     

    ‐

    20

     

    ‐

     

    20

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

    ‐

     

    ‐

    1

     

    ‐

     

    1

    Other (income) expenses

    (8)

     

    22

    1

     

    7

    105

     

    2

     

    129

    Earnings (loss) before finance costs and income taxes

    149

     

    157

    301

     

    9

    (246)

     

    27

     

    397

    Depreciation and amortization

    191

     

    134

    170

     

    77

    18

     

    ‐

     

    590

    EBITDA

    340

     

    291

    471

     

    86

    (228)

     

    27

     

    987

    Restructuring costs

    ‐

     

    ‐

    ‐

     

    ‐

    47

     

    ‐

     

    47

    Share-based compensation expense

    ‐

     

    ‐

    ‐

     

    ‐

    20

     

    ‐

     

    20

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

    ‐

     

    ‐

    1

     

    ‐

     

    1

    ARO/ERL related income for non-operating sites

    ‐

     

    ‐

    ‐

     

    ‐

    (1)

     

    ‐

     

    (1)

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

    ‐

     

    ‐

    1

     

    ‐

     

    1

    Adjusted EBITDA

    340

     

    291

    471

     

    86

    (160)

     

    27

     

    1,055

    1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

     

     

    Twelve Months Ended December 31, 2025

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    17,601

     

    3,571

     

    3,807

     

    1,660

     

    246

     

    ‐

     

    26,885

     

    – intersegment

    19

     

    424

     

    932

     

    298

     

    ‐

     

    (1,673)

     

    ‐

    Sales

    – total

    17,620

     

    3,995

     

    4,739

     

    1,958

     

    246

     

    (1,673)

     

    26,885

    Freight, transportation and

    distribution 1

    ‐

     

    402

     

    552

     

    224

     

    (1)

     

    (241)

     

    936

    Net sales

    17,620

     

    3,593

     

    4,187

     

    1,734

     

    247

     

    (1,432)

     

    25,949

    Cost of goods sold

    13,017

     

    1,581

     

    2,580

     

    1,590

     

    220

     

    (1,386)

     

    17,602

    Gross margin

    4,603

     

    2,012

     

    1,607

     

    144

     

    27

     

    (46)

     

    8,347

    Selling expenses (recovery)

    3,306

     

    10

     

    26

     

    6

     

    (1)

     

    (27)

     

    3,320

    General and administrative expenses

    172

     

    10

     

    18

     

    8

     

    392

     

    ‐

     

    600

    Provincial mining taxes

    ‐

     

    372

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    372

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    163

     

    ‐

     

    163

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    9

     

    ‐

     

    9

    Gain on sale of investment in Profertil

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (301)

     

    ‐

     

    (301)

    Other expenses

    123

     

    26

     

    32

     

    33

     

    207

     

    27

     

    448

    Earnings (loss) before finance costs and income taxes

    1,002

     

    1,594

     

    1,531

     

    97

     

    (442)

     

    (46)

     

    3,736

    Depreciation and amortization

    734

     

    660

     

    616

     

    285

     

    74

     

    ‐

     

    2,369

    EBITDA

    1,736

     

    2,254

     

    2,147

     

    382

     

    (368)

     

    (46)

     

    6,105

    Restructuring costs

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    68

     

    ‐

     

    68

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    163

     

    ‐

     

    163

    ARO/ERL related expenses for non-operating sites

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    2

     

    ‐

     

    2

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    9

     

    ‐

     

    9

    Gain on sale of investment in Profertil

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (301)

     

    ‐

     

    (301)

    Adjusted EBITDA

    1,736

     

    2,254

     

    2,147

     

    382

     

    (427)

     

    (46)

     

    6,046

    1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

     

     

    Twelve Months Ended December 31, 2024

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

    Nitrogen1

     

    Phosphate

    and Others1

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    17,832

     

    3,008

    3,327

     

    1,610

    195

     

    ‐

     

    25,972

     

    – intersegment

    ‐

     

    370

    807

     

    278

    ‐

     

    (1,455)

     

    ‐

    Sales

    – total

    17,832

     

    3,378

    4,134

     

    1,888

    195

     

    (1,455)

     

    25,972

    Freight, transportation and

    distribution 2

    ‐

     

    389

    558

     

    231

    4

     

    (226)

     

    956

    Net sales

    17,832

     

    2,989

    3,576

     

    1,657

    191

     

    (1,229)

     

    25,016

    Cost of goods sold

    13,211

     

    1,448

    2,374

     

    1,510

    170

     

    (1,227)

     

    17,486

    Gross margin

    4,621

     

    1,541

    1,202

     

    147

    21

     

    (2)

     

    7,530

    Selling expenses (recovery)

    3,418

     

    10

    24

     

    6

    2

     

    (25)

     

    3,435

    General and administrative expenses

    191

     

    12

    22

     

    14

    405

     

    ‐

     

    644

    Provincial mining taxes

    ‐

     

    255

    ‐

     

    ‐

    ‐

     

    ‐

     

    255

    Share-based compensation expense

    ‐

     

    ‐

    ‐

     

    ‐

    37

     

    ‐

     

    37

    Impairment of assets

    335

     

    ‐

    195

     

    ‐

    ‐

     

    ‐

     

    530

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

    ‐

     

    ‐

    360

     

    ‐

     

    360

    Other expenses (income)

    87

     

    25

    (135)

     

    33

    379

     

    24

     

    413

    Earnings (loss) before finance costs and income taxes

    590

     

    1,239

    1,096

     

    94

    (1,162)

     

    (1)

     

    1,856

    Depreciation and amortization

    771

     

    609

    589

     

    290

    80

     

    ‐

     

    2,339

    EBITDA

    1,361

     

    1,848

    1,685

     

    384

    (1,082)

     

    (1)

     

    4,195

    Restructuring costs

    ‐

     

    ‐

    ‐

     

    ‐

    47

     

    ‐

     

    47

    Share-based compensation expense

    ‐

     

    ‐

    ‐

     

    ‐

    37

     

    ‐

     

    37

    Impairment of assets

    335

     

    ‐

    195

     

    ‐

    ‐

     

    ‐

     

    530

    Loss related to financial instruments in Argentina

    ‐

     

    ‐

    ‐

     

    ‐

    35

     

    ‐

     

    35

    ARO/ERL related expenses for non-operating sites

    ‐

     

    ‐

    ‐

     

    ‐

    151

     

    ‐

     

    151

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

    ‐

     

    ‐

    360

     

    ‐

     

    360

    Adjusted EBITDA

    1,696

     

    1,848

    1,880

     

    384

    (452)

     

    (1)

     

    5,355

    1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Retail sales by product line

     

     

     

     

     

     

     

    Crop nutrients

    1,512

     

    1,528

     

    7,285

     

    7,211

    Crop protection products

    931

     

    948

     

    6,105

     

    6,313

    Seed

    162

     

    184

     

    2,128

     

    2,235

    Services and other

    254

     

    228

     

    944

     

    918

    Merchandise

    226

     

    230

     

    875

     

    897

    Nutrien Financial

    82

     

    77

     

    376

     

    361

    Nutrien Financial elimination 1

    (23)

     

    (16)

     

    (93)

     

    (103)

     

    3,144

     

    3,179

     

    17,620

     

    17,832

    Potash sales by geography

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    North America

    278

     

    245

     

    1,727

     

    1,719

    Offshore 2

    514

     

    342

     

    2,264

     

    1,658

    Other potash and purchased products

    ‐

     

    ‐

     

    4

     

    1

     

    792

     

    587

     

    3,995

     

    3,378

    Nitrogen sales by product line

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    Ammonia

    319

     

    376

     

    1,218

     

    1,232

    Urea and ESN®

    360

     

    395

     

    1,648

     

    1,480

    Solutions, nitrates and sulfates

    424

     

    339

     

    1,641

     

    1,300

    Other nitrogen and purchased products 3

    137

     

    33

     

    232

     

    122

     

    1,240

     

    1,143

     

    4,739

     

    4,134

    Phosphate sales by product line

     

     

     

     

     

     

     

    Manufactured product

     

     

     

     

     

     

     

    Fertilizer

    362

     

    309

     

    1,275

     

    1,237

    Industrial and feed

    177

     

    157

     

    661

     

    627

    Other phosphate and purchased products

    4

     

    5

     

    22

     

    24

     

    543

     

    471

     

    1,958

     

    1,888

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    2 Relates to Canpotex Limited ("Canpotex") (see Note 10) and includes provisional pricing adjustments for the three months ended December 31, 2025 of $3 million (2024 – $(3) million) and the twelve months ended December 31, 2025 of $48 million (2024 – $4 million).

    3 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    Note 3 Impairment of assets

    During the three and twelve months ended December 31, 2025, we assessed our assets for indicators of impairment. No impairment was recognized during the year.

    Nitrogen

    At December 31, 2025, circumstances within our Trinidad cash generating unit (CGU) presented an indicator of impairment. On October 23, 2025, the Trinidad nitrogen facility completed a controlled shutdown in response to port access restrictions imposed by Trinidad and Tobago's National Energy Corporation and a lack of reliable and economic natural gas supply. As a result, we performed impairment testing on our Trinidad CGU, part of our Nitrogen segment. No impairment was recognized, as the recoverable amount of the Trinidad CGU exceeded its carrying amount. The recoverable amount was determined using a fair value less costs of disposal ("FVLCD") methodology. The valuation was based on post-tax discounted cash flows using a 10-year projection and a 2.0% terminal growth rate discounted at a post-tax rate of 11.8%.

    Goodwill impairment testing

    As at December 31 ($ millions)

    2025

     

    2024

    Goodwill by CGU or Group of CGUs

     

     

     

    Retail – North America

    7,006

     

    6,961

    Retail – Australia

    587

     

    539

    Potash

    154

     

    154

    Nitrogen

    4,389

     

    4,389

     

    12,136

     

    12,043

    During the three and twelve months ended December 31, 2025, we performed our annual impairment test on goodwill and did not identify any impairment.

    In testing for impairment of goodwill, we calculate the recoverable amount for a CGU or groups of CGUs containing goodwill. We used the FVLCD methodology based on post-tax discounted cash flows (five-year or 10-year projections plus a terminal value) and incorporated assumptions an independent market participant would apply. We adjusted discount rates for each CGU or group of CGUs for the risk associated with achieving our forecasts and for the country risk premium in which we expect to generate cash flows. FVLCD is a Level 3 measurement. We use our market capitalization (where applicable) and comparative market multiples to ensure discounted cash flow results are reasonable.

    The key assumptions with the greatest influence on the calculation of the recoverable amounts are the discount rates, terminal growth rates and forecasted EBITDA. The key forecast assumptions were based on historical data and our estimates of future results from internal sources considering industry and market information.

    Retail – North America CGU

    During our performance of our annual impairment test, the Retail – North America group of CGUs recoverable amount exceeded its carrying amount by $2.9 billion. Goodwill is more susceptible to impairment risk if there is an increase in the discount rate or a deterioration in business operating results or economic conditions and actual results do not meet our forecasts. A reduction in the terminal growth rate, an increase in the discount rate or a decrease in forecasted EBITDA could cause impairment in the future as shown in the table below.

     

     

    Key assumption

     

    Change required for carrying amount

    2025 Annual impairment testing

     

    used in impairment model

     

    to equal recoverable amount

    Terminal growth rate (%)

     

    2.3

     

    1.8

    Percentage point decrease

    Discount rate 1 (%)

     

    7.7

     

    1.2

    Percentage point increase

    Forecasted EBITDA over forecast period ($ millions)

     

    8,500

     

    12

    Percent decrease

    1 The discount rate used in the previous measurement at October 1, 2024 was 7.3 percent.

    Retail – Australia, Potash, and Nitrogen CGUs

    The following table indicates the key assumptions used in testing the remaining groups of CGUs:

     

    Terminal growth rate (%)

     

    Post-tax discount rate (%)

     

    2025

     

    2024

     

    2025

     

    2024

    Retail – Australia

    2.5

     

    2.6

     

    7.6

     

    7.9

    Potash

    2.0

     

    2.5

     

    7.3

     

    6.3

    Nitrogen

    2.0

     

    2.3

     

    8.7

     

    7.6

    2024 Impairment of assets

    In the twelve months ended December 31, 2024, we recorded the following non-cash impairment of assets in the condensed consolidated statements of earnings:

     

     

     

    ($ millions)

     

    December 31, 2024

    Segment

    Category

     

     

    Retail

    Intangible assets

     

    200

     

    Property, plant and equipment

     

    120

     

    Other

     

    15

    Nitrogen

    Property, plant and equipment

     

    195

    Impairment of assets

     

    530

    Note 4 Other expenses (income)

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Restructuring costs

    46

     

    47

     

    68

     

    47

    Earnings of equity-accounted investees

    (1)

     

    (23)

     

    (37)

     

    (130)

    Bad debt (recovery) expense

    (3)

     

    23

     

    85

     

    117

    Project feasibility costs

    39

     

    26

     

    108

     

    92

    Customer prepayment costs

    13

     

    12

     

    63

     

    58

    Legal expenses

    8

     

    15

     

    21

     

    47

    ARO/ERL related expenses (income) for non-operating sites 1

    9

     

    (1)

     

    2

     

    151

    Loss on natural gas derivatives not designated as a hedge

    ‐

     

    1

     

    ‐

     

    8

    Loss related to financial instruments in Argentina

    ‐

     

    1

     

    ‐

     

    35

    Insurance recoveries

    ‐

     

    (3)

     

    (1)

     

    (65)

    Other expenses

    66

     

    31

     

    139

     

    53

     

    177

     

    129

     

    448

     

    413

    1 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

    Note 5 Income taxes

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Actual effective tax rate on earnings (%)

    21

     

    33

     

    24

     

    40

    Actual effective tax rate including discrete items (%)

    22

     

    42

     

    25

     

    38

    Discrete tax adjustments that impacted the tax rate 1

    4

     

    18

     

    27

     

    (13)

    1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

    Note 6 Investments

     

     

     

     

     

    Proportion of

    Ownership Interest and

     

     

     

     

     

     

     

     

    Voting Rights Held (%)

     

    Carrying Amount

    ($ millions, except as otherwise noted)

    Principal

    Activity

     

    Principal

    Place of

    Business and

    Incorporation

     

    As at

    December 31,

    2025

    As at

    December 31,

    2024

     

    As at

    December 31,

    2025

    As at

    December 31,

    2024

    Equity-accounted investees

     

     

     

     

     

     

     

     

    Profertil S.A. ("Profertil")

    Nitrogen producer

     

    Argentina

     

    ‐

    50

     

    ‐

    349

    Canpotex

    Marketing and

    logistics of potash

     

    Canada

     

    50

    50

     

    ‐

    ‐

    Other associates and joint ventures

     

     

     

     

     

     

    134

    128

    Total equity-accounted investees

     

     

     

     

     

     

    134

    477

    Investments at FVTOCI

     

     

     

     

     

    Sinofert Holdings Limited ("Sinofert")

    Fertilizer supplier

    and distributor

     

    China/Bermuda

     

    ‐

    19

     

    ‐

    211

    Other

     

     

     

     

     

     

     

    10

    10

    Total investments at FVTOCI

     

     

     

     

     

     

    10

    221

    Total investments

     

     

     

     

     

     

    144

    698

    Equity-accounted investees

    In 2025, as part of our strategic priority to simplify and focus, we entered into an agreement to sell our 50 percent equity ownership in Profertil, which had been classified as an equity-accounted investment. A deposit of $120 million was received from the purchaser on September 5, 2025. The sale closed on December 10, 2025 resulting in gross proceeds of $595 million and a gain of $301 million recorded in the consolidated statement of earnings within our Corporate and Others segment. This gain reflects the difference between the net proceeds and the carrying amount of the investment at the date of sale. The buyer remitted the applicable withholding tax on behalf of Nutrien, resulting in a $60 million non-cash transaction.

    Investments at fair value through other comprehensive income

    In 2025, as part of our strategic priority to simplify and focus, we fully divested our remaining equity ownership interest in Sinofert, which had been classified as a financial asset measured at fair value through other comprehensive income. Gross proceeds from the sale were $193 million and reflected the fair value of the investment at the date of derecognition. A fair value loss of $18 million related to the investment was recognized in other comprehensive income. Upon derecognition, the cumulative unrealized gain previously recognized in other comprehensive income of $27 million was reclassified to retained earnings.

    Note 7 Financial instruments

    Foreign currency derivatives

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    ($ millions)

    2025

     

    2024

     

    2025

     

    2024

    Foreign exchange loss (gain)

    7

     

    (13)

     

    (2)

     

    14

    Hyperinflationary loss 1

    ‐

     

    12

     

    ‐

     

    97

    (Gain) loss on foreign currency derivatives at fair value through profit or loss ("FVTPL")

    (16)

     

    2

     

    11

     

    249

    Foreign exchange (gain) loss, net of related derivatives

    (9)

     

    1

     

    9

     

    360

    1 In 2025, the functional currency of our Argentina operations changed from the Argentine peso to the US dollar and was applied prospectively from the date of change, eliminating the need for hyperinflationary adjustments.

    Our financial instruments carrying amounts are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $9,863 million and fair value of $9,476 million as at December 31, 2025. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

    Note 8 Debt

    In 2025, we extended the maturity of our $4,500 million unsecured committed revolving term facility to September 4, 2030. We also extended the term of our unsecured committed revolving term credit facility to September 2, 2026 and reduced the facility limit from $750 million to $500 million.

    ($ millions, except as otherwise noted)

    Rate of interest (%)

     

    Maturity

     

    Amount

    Senior notes repaid in 2025

    3.000

     

    April 1, 2025

     

    500

    Senior notes repaid in 2025

    5.950

     

    November 7, 2025

     

    500

     

     

     

     

     

    1,000

     

     

     

     

     

     

    Senior notes issued in 2025

    4.500

     

    March 12, 2027

     

    400

    Senior notes issued in 2025

    5.250

     

    March 12, 2032

     

    600

     

     

     

     

     

    1,000

    The senior notes issued in the twelve months ended December 31, 2025, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series of outstanding senior notes is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

    Note 9 Share capital

    Share repurchase programs

    The following table summarizes our share repurchase activities during the periods indicated below:

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31

     

    December 31

    ($ millions, except as otherwise noted)

    2025

     

    2024

     

    2025

     

    2024

    Number of common shares repurchased for cancellation

    2,540,498

     

    2,905,718

     

    9,829,408

     

    3,944,903

    Average price per share (US dollars)

    58.76

     

    47.02

     

    55.94

     

    47.31

    Total cost, inclusive of tax

    151

     

    139

     

    560

     

    190

    Subsequent to December 31, 2025, as of February 17, 2026, an additional 1,097,694 common shares were repurchased for cancellation at a cost of $73 million and an average price per share of $66.97.

    On February 18, 2026, our Board of Directors approved a share repurchase program for up to five percent of our outstanding common shares. The 2026 normal course issuer bid, which is subject to the acceptance by the Toronto Stock Exchange, will expire after a 12-month period, if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.

    Dividends declared

    We declared a dividend per share of $0.545 (2024 – $0.54) during the three months ended December 31, 2025, payable on January 16, 2026 to shareholders of record on December 31, 2025.

    On February 18, 2026, our Board of Directors declared and increased our quarterly dividend to $0.55 per share payable on April 16, 2026, to shareholders of record on March 31, 2026. The total estimated dividend to be paid is $265 million.

    Note 10 Related party transactions

    We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended December 31, 2025 were $50 million (2024 – $34 million) and the twelve months ended December 31, 2025 were $150 million (2024 – $146 million).

     

     

    As at

     

    As at

    ($ millions)

     

    December 31, 2025

     

    December 31, 2024

    Receivables from Canpotex

     

    279

     

    122

    Payables to Canpotex

     

    63

     

    66

    Note 11 Accounting policies, estimates and judgments

    Amendments to IFRS 9 and IFRS 7, Classification and Measurement of Financial Instruments, issued in May 2024, describe the timing of recognition and derecognition for a financial asset or financial liability, including clarifying that a financial liability is derecognized on the settlement date. In addition to these clarifications, the amendments introduce an accounting policy choice to derecognize financial liabilities settled using an electronic payment system before the settlement date if specific conditions are met. These amendments will be effective January 1, 2026, and will not apply to comparative information. Nutrien has reviewed its banking procedures and assessed that the impact of the amendment is immaterial as at January 1, 2026.

    IFRS 18, Presentation and Disclosure in Financial Statements, issued in April 2024, would replace IAS 1, Presentation of Financial Statements, and introduce new presentation requirements, including defined subtotals and enhances guidance on aggregation and disaggregation. IFRS 18 will be effective January 1, 2027, and will also apply to comparative information. We are reviewing the standard to determine the potential impact.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260210872647/en/

    Investor Contact:

    Jeff Holzman

    Senior Vice President, Investor Relations and FP&A

    (306) 933-8545 – [email protected]

    Media Contact:

    Simon Scott

    Vice President, Global Communications

    (403) 225-7213 – [email protected]

    Get the next $NTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTR

    DatePrice TargetRatingAnalyst
    1/14/2026$77.00Equal-Weight → Overweight
    Morgan Stanley
    11/11/2025$64.00Equal Weight
    Wells Fargo
    10/14/2025$67.00Buy → Neutral
    BofA Securities
    9/5/2025Sector Perform
    National Bank Financial
    7/11/2025$66.00Buy → Hold
    Jefferies
    6/17/2025$68.00Outperform → Mkt Perform
    Raymond James
    5/14/2025$62.00Sector Outperform → Sector Perform
    Scotiabank
    3/13/2025$53.00Sell
    Goldman
    More analyst ratings

    $NTR
    SEC Filings

    View All

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    12/10/25 4:30:14 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    10/21/25 9:50:05 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    9/8/25 7:28:02 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nutrien Reports Full-Year 2025 Results and Provides 2026 Guidance

    Full-year results demonstrate strong execution of our strategic plan and progress towards 2026 performance targets. 2026 guidance reflects growth in upstream fertilizer sales volumes from our North American plants, higher Retail earnings, and a disciplined and consistent approach to capital allocation. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its fourth quarter 2025 results, with net earnings of $0.58 billion ($1.18 diluted net earnings per share). Fourth quarter 2025 adjusted EBITDA1 was $1.28 billion and adjusted net earnings per share1 was $0.83. "2025 was a defining year for our Company, with exceptional performa

    2/18/26 5:26:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Increases Quarterly Dividend and Announces Intent to Launch a New Share Repurchase Program

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors declared a quarterly dividend of US$0.55 per share payable on April 16, 2026 to shareholders of record on March 31, 2026. This represents an approximately one percent increase from the prior dividend declared on November 5, 2025 and equates to an annualized dividend of US$2.20 per share. The Board also approved the purchase of up to five percent of Nutrien's issued and outstanding common shares over a twelve-month period through a normal course issuer bid (NCIB). Any purchases of common shares will be subject to acceptance by the Toronto Stock Exchange of Nutrien's notice to commence a NCIB. Registered sharehold

    2/18/26 5:21:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for Fourth Quarter 2025 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release fourth quarter 2025 results after market close on Wednesday, February 18. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EST on Thursday, February 19. Investors can access the call by dialing 1-800-990-2777 or 1-416-855-9085 and using conference ID: 93473. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at: www.nutrien.com/investors/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provi

    1/20/26 6:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nutrien upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Nutrien from Equal-Weight to Overweight and set a new price target of $77.00

    1/14/26 8:22:27 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Wells Fargo resumed coverage on Nutrien with a new price target

    Wells Fargo resumed coverage of Nutrien with a rating of Equal Weight and set a new price target of $64.00

    11/11/25 8:06:04 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien downgraded by BofA Securities with a new price target

    BofA Securities downgraded Nutrien from Buy to Neutral and set a new price target of $67.00

    10/14/25 8:42:17 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Financials

    Live finance-specific insights

    View All

    Nutrien Reports Full-Year 2025 Results and Provides 2026 Guidance

    Full-year results demonstrate strong execution of our strategic plan and progress towards 2026 performance targets. 2026 guidance reflects growth in upstream fertilizer sales volumes from our North American plants, higher Retail earnings, and a disciplined and consistent approach to capital allocation. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its fourth quarter 2025 results, with net earnings of $0.58 billion ($1.18 diluted net earnings per share). Fourth quarter 2025 adjusted EBITDA1 was $1.28 billion and adjusted net earnings per share1 was $0.83. "2025 was a defining year for our Company, with exceptional performa

    2/18/26 5:26:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Increases Quarterly Dividend and Announces Intent to Launch a New Share Repurchase Program

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors declared a quarterly dividend of US$0.55 per share payable on April 16, 2026 to shareholders of record on March 31, 2026. This represents an approximately one percent increase from the prior dividend declared on November 5, 2025 and equates to an annualized dividend of US$2.20 per share. The Board also approved the purchase of up to five percent of Nutrien's issued and outstanding common shares over a twelve-month period through a normal course issuer bid (NCIB). Any purchases of common shares will be subject to acceptance by the Toronto Stock Exchange of Nutrien's notice to commence a NCIB. Registered sharehold

    2/18/26 5:21:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for Fourth Quarter 2025 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release fourth quarter 2025 results after market close on Wednesday, February 18. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EST on Thursday, February 19. Investors can access the call by dialing 1-800-990-2777 or 1-416-855-9085 and using conference ID: 93473. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at: www.nutrien.com/investors/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provi

    1/20/26 6:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Leadership Updates

    Live Leadership Updates

    View All

    Nutrien Announces Results of 2025 Annual Meeting

    Nutrien Ltd. (TSX and NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 7, 2025 (the "Meeting"). A total of 488,556,988 common shares, representing 74.48% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.02% 1.98% Maura J. Clark 98.88% 1.12% Russell K. Girling 96.64% 3.36% Michael J. Hennigan 96.21% 3.79% Miranda C. Hubbs 98.20% 1.80% Raj S. Kushwaha 98.88% 1.12%

    5/7/25 8:31:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2024 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 8, 2024 (the "Meeting"). A total of 369,251,444 common shares, representing 74.66% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.33% 1.67% Maura J. Clark 98.95% 1.05% Russell K. Girling 98.31% 1.69% Michael J. Hennigan 94.88% 5.12% Miranda C. Hubbs 98.48% 1.52%

    5/8/24 7:11:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2023 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 10, 2023 (the "Meeting"). A total of 386,934,221 common shares, representing 77.42% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 95.86% 4.14% Maura J. Clark 95.57% 4.43% Russell K. Girling 93.30% 6.70% Michael J. Hennigan 91.15% 8.85% Miranda C. Hubbs 95.80% 4.20

    5/10/23 7:44:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials